Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Preliminary Study of the Efficacy and Safety of Carbamazepine in Severe Liver Disease Due to Alpha-1 Antitrypsin Deficiency

NCT01379469 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT01379469
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01379469 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Preliminary Study of the Efficacy and Safety of Carbamazepine in Severe Liver Disease Due to Alpha-1 Antitrypsin Deficiency
Lead sponsor
Washington University School of Medicine
Phase
Phase 2
Overall status
Terminated
Start date
January 31, 2012
Completion date
February 28, 2017
Enrollment
20 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

alpha-1-antitrypsin deficiency, liver cirrhosis